You’re in safe hands. Over 10 years of research has led to a state-of-the-art molecular diagnostic test for five genotypic biomarkers in the urine. The test provides a score that helps doctors accurately diagnose bladder cancer.
Our research shows that messenger RNA (mRNA) levels of five biomarker genes are present at higher levels in urine from patients with, rather than without, bladder cancer.1
Only a small sample of mid-stream urine is needed for the Cxbladder test. At the laboratory, the urine sample undergoes several precise processes to extract and purify the mRNA present.
We then use a process called Reverse Transcription quantitative Polymerase Chain Reaction (RT-qPCR) to amplify and measure the biomarker genes of interest.
It is the quantity of these biomarker genes in relation to each other that we use to calculate a Cxbladder test score.
Last Updated: 09 Sep 2021 05:14 pm
-
References
1 Holyoake A, O’Sullivan P, Pollock R, et al. Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder. Clin Cancer Res 2008;14:742–9.
How does Cxbladder work
Find out more about the science behind the test.
-
Talk to your doctor
Are you alarmed about blood in your urine? Worried about bladder cancer? Download our patient discussion guide for a list of questions you can ask your doctor.
Download discussion guide now -
Get Cxbladder
Contact us by phone or email, or fill out an online form and a Cxbladder representative will get back to you.
Complete an information request form today